- Company however does plan to offer larger discounts at the time of purchase.
- Also plans to stop offering discounts on NEULASTA and NEUPOGEN.
- The move follows concerns by critics who said that by the company offering discounts on various drugs, it provided an incentive for doctors to use more of the drugs.
- The price changes will take effect on Oct 1.

Other headlines for [AMGN]

• AMGN 11/21/2008 08:24am
  Amgen Inc Update: EU's CHMP adopts positive opinion on marketing authorization on Nplate for treatment of adult chronic immune idiopathic thrombocytopenic purpura
  
• AMGN 11/21/2008 06:26am
  Amgen Inc Added to Top Picks Live List at Citi
  
• AMGN 11/19/2008 06:57pm
  Amgen Inc Enrollment in Phase III MONET1 trial has been temporarily suspended- Enrollment in the Phase III MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the more...
  
• AMGN 11/18/2008 11:19am
  Amgen Inc Exec: Amgen pipeline drug Denosumab seems promising in a cancer setting; co. would consider licensing deals for other cancer products
  
• MRK 11/12/2008 09:51am
  Merck & Co Inc FDA updates on bisphosphonates safety trials, notes it is seeking more data for heart rhythm disorder stemming from use of the compound- Does not want to change rules for use of bisphosphonates for more...
  

Healthcare sector headlines

• CUR Today 08:02am
  Neuralstem Inc Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials- The collaboration will focus on Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with Dr. more...
  
• SVA Today 08:01am
  Sinovac Biotech Announces share buyback of up to $2M (5.5% of market cap)
  
• PRX Today 08:01am
  Par Pharmaceutical Companies Inc. Announces successful completion of Bioequivalence Studies for Ondansetron Thin Film- The ondansetron thin film product is being developed for the prevention of chemotherapy-induced nausea and more...
  
• CSKI Today 08:01am
  China Sky One Medical, Inc. Names Yu-Bo Hao new CFO- He replaces Yu-kun Zhang, who had served as interim CFO since June, 2008. - Mr. Hao has been employed at China Sky One in various capacities since June, 2008. - From more...
  
• THRX Today 08:01am
  Theravance Inc Announces positive Phase 2b results for LABA, '444 in the Horizon Asthma Development Programme with GSK- The study, which was designed to evaluate the efficacy of five doses of '444 administered more...